Web Date: July 18, 2014
AbbVie And Shire Agree On Merger
After pursuing the specialty pharmaceutical firm Shire for months, Illinois-based AbbVie has finally convinced it to merge. AbbVie will pay about $54 billion in cash and stock to the Irish firm’s shareholders, who will end up with a 25% ownership stake in the new company.
“We believe that this offer reflects the substantial value that we have already created for Shire’s shareholders and the strength of our future prospects,” said Susan . . .
To view the rest of this content, please log in with your ACS ID.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society